NR4A1 and breast carcinoma: However, it is still unclear if the benefit of chemotherapy in premenopausal women with hormone receptor-positive early breast cancer is due to the direct cytotoxic effect of chemotherapy or to the induction of chemotherapy-induced amenorrhea.